摘要:
The present invention relates to antibody molecules capable of specifically recognizing two regions of the β-A4 peptide, wherein the first region comprises the amino acid sequence AEFRHDSGY as shown in SEQ ID NO: 1 or a fragment thereof and wherein the second region comprises the amino acid sequence VHHQKLVFFAEDVG as shown in SEQ ID NO: 2 or a fragment thereof. Furthermore, nucleic acid molecules encoding the inventive antibody molecules and vectors and hosts comprising said nucleic acid molecules are disclosed. In addition, the present invention provides for compositions, preferably pharmaceutical or diagnostic compositions, comprising the compounds of the invention as well as for specific uses of the antibody molecules, nucleic acid molecules, vectors or hosts of the invention.
摘要翻译:本发明涉及能够特异性识别β-A4肽的两个区域的抗体分子,其中第一区域包含如SEQ ID NO:1所示的氨基酸序列AEFRHDSGY或其片段,其中第二区域包含 如SEQ ID NO:2所示的氨基酸序列VHHQKLVFFAEDVG或其片段。 此外,公开了编码本发明抗体分子的核酸分子和包含所述核酸分子的载体和宿主。 此外,本发明提供包含本发明化合物以及本发明的抗体分子,核酸分子,载体或宿主的特定用途的组合物,优选药物或诊断组合物。
摘要:
The present invention relates to antibody molecules capable of specifically recognizing two regions of the β-A4 peptide, wherein the first region comprises the amino acid sequence AEFRHDSGY as shown in SEQ ID NO: 1 or a fragment thereof and wherein the second region comprises the amino acid sequence VHHQKLVFFAEDVG as shown in SEQ ID NO: 2 or a fragment thereof. Furthermore, nucleic acid molecules encoding the inventive antibody molecules and vectors and hosts comprising said nucleic acid molecules are disclosed. In addition, the present invention provides for compositions, preferably pharmaceutical or diagnostic compositions, comprising the compounds of the invention as well as for specific uses of the antibody molecules, nucleic acid molecules, vectors or hosts of the invention.
摘要翻译:本发明涉及能够特异性识别β-A4肽的两个区域的抗体分子,其中第一区域包含如SEQ ID NO:1所示的氨基酸序列AEFRHDSGY或其片段,其中第二区域包含 如SEQ ID NO:2所示的氨基酸序列VHHQKLVFFAEDVG或其片段。 此外,公开了编码本发明抗体分子的核酸分子和包含所述核酸分子的载体和宿主。 此外,本发明提供包含本发明化合物以及本发明的抗体分子,核酸分子,载体或宿主的特定用途的组合物,优选药物或诊断组合物。
摘要:
The present invention relates to a purified antibody molecule preparation being characterized in that at least one antigen binding site comprises a glycosylated asparagine (Asn) in the variable region of the heavy chain (VH). More specifically, a pharmaceutical and a diagnostic composition comprising said antibody molecule and antibody mixtures are provided which is/are capable of specifically recognizing the β-A4 peptide/Aβ4. The present invention relates in particular to a mixture of antibodies comprising one or two glycosylated antigen binding sites with a glycosylated asparagine (Asn) in the variable region of the heavy chain, i.e. mixtures of isoforms of antibodies which comprise a glycosylated Asn in the variable region of the heavy chain (VH). Also disclosed are compositions or antibody preparations comprising the specifically glycosylated antibody isoforms. Furthermore, the pharmaceutical and diagnostic uses for these antibodies are provided. The antibody isoforms may for example be used in the pharmaceutical intervention of amyloidogenesis or amyloid-plaque formation and/or in the diagnosis of the same.
摘要:
The present invention relates to a transgenic non-human animal whose genome comprises a) a first transgenic DNA sequence encoding a human APP Swedish or a human APP London protein, wherein said first transgenic DNA sequence is operably linked to a first promoter; b) a second transgenic DNA sequence encoding a human Presenilin 2 protein comprising a N141I substitution, wherein said second transgenic DNA sequence is operably linked to a second promoter; c) a third transgenic DNA sequence encoding a light chain of a antibody directed against the amyloid peptide, wherein said third transgenic DNA sequence is operably linked to a third promoter and; d) a forth transgenic DNA sequence encoding a heavy chain of said antibody, wherein said forth transgenic is operably linked to the third promoter or to a forth promoter, and methods for producing said animal.
摘要:
The present invention relates to antibody molecules capable of specifically recognizing two regions of the β-A4 peptide, wherein the first region comprises the amino acid sequence AEFRHDSGY as shown in SEQ ID NO: 1 or a fragment thereof and wherein the second region comprises the amino acid sequence VHHQKLVFFAEDVG as shown in SEQ ID NO: 2 or a fragment thereof. Furthermore, nucleic acid molecules encoding the inventive antibody molecules and vectors and hosts comprising said nucleic acid molecules are disclosed. In addition, the present invention provides for compositions, preferably pharmaceutical or diagnostic compositions, comprising the compounds of the invention as well as for specific uses of the antibody molecules, nucleic acid molecules, vectors or hosts of the invention.
摘要翻译:本发明涉及能够特异性识别β-A4肽的两个区域的抗体分子,其中第一区域包含如SEQ ID NO:1所示的氨基酸序列AEFRHDSGY或其片段,其中第二区域包含 如SEQ ID NO:2所示的氨基酸序列VHHQKLVFFAEDVG或其片段。 此外,公开了编码本发明抗体分子的核酸分子和包含所述核酸分子的载体和宿主。 此外,本发明提供包含本发明化合物以及本发明的抗体分子,核酸分子,载体或宿主的特定用途的组合物,优选药物或诊断组合物。
摘要:
The present invention relates to antibody molecules capable of specifically recognizing two regions of the β-A4 peptide, wherein the first region comprises the amino acid sequence AEFRHDSGY as shown in SEQ ID NO: 1 or a fragment thereof and wherein the second region comprises the amino acid sequence VHHQKLVFFAEDVG as shown in SEQ ID NO: 2 or a fragment thereof. Furthermore, nucleic acid molecules encoding the inventive antibody molecules and vectors and hosts comprising said nucleic acid molecules are disclosed. In addition, the present invention provides for compositions, preferably pharmaceutical or diagnostic compositions, comprising the compounds of the invention as well as for specific uses of the antibody molecules, nucleic acid molecules, vectors or hosts of the invention.
摘要翻译:本发明涉及能够特异性识别β-A4肽的两个区域的抗体分子,其中第一区域包含如SEQ ID NO:1所示的氨基酸序列AEFRHDSGY或其片段,其中第二区域包含 如SEQ ID NO:2所示的氨基酸序列VHHQKLVFFAEDVG或其片段。 此外,公开了编码本发明抗体分子的核酸分子和包含所述核酸分子的载体和宿主。 此外,本发明提供包含本发明化合物以及本发明的抗体分子,核酸分子,载体或宿主的特定用途的组合物,优选药物或诊断组合物。
摘要:
The present invention relates to a purified antibody molecule preparation being characterized in that at least one antigen binding site comprises a glycosylated asparagine (Asn) in the variable region of the heavy chain (VH). More specifically, a pharmaceutical and a diagnostic composition comprising said antibody molecule and antibody mixtures are provided which is/are capable of specifically recognizing the β-A4 peptide/Aβ4. The present invention relates in particular to a mixture of antibodies comprising one or two glycosylated antigen binding sites with a glycosylated asparagine (Asn) in the variable region of the heavy chain, i.e. mixtures of isoforms of antibodies which comprise a glycosylated Asn in the variable region of the heavy chain (VH). Also disclosed are compositions or antibody preparations comprising the specifically glycosylated antibody isoforms. Furthermore, the pharmaceutical and diagnostic uses for these antibodies are provided. The antibody isoforms may for example be used in the pharmaceutical intervention of amyloidogenesis or amyloid-plaque formation and/or in the diagnosis of the same.
摘要:
The present invention relates to antibody molecules capable of specifically recognizing two regions of the R-A4 peptide, wherein the first region comprises the amino acid sequence AEFRHDSGY as shown in SEQ ID NO: 1 or a fragment thereof and wherein the second region comprises the amino acid sequence VHHQKLVFFAEDVG as shown in SEQ ID NO: 2 or a fragment thereof. Furthermore, nucleic acid molecules encoding the inventive antibody molecules and vectors and hosts comprising said nucleic acid molecules are disclosed. In addition, the present invention provides for compositions, preferably pharmaceutical or diagnostic compositions, comprising the compounds of the invention as well as for specific uses of the antibody molecules, nucleic acid molecules, vectors or hosts of the invention.
摘要翻译:本发明涉及能够特异性识别R-A4肽的两个区域的抗体分子,其中第一区域包含如SEQ ID NO:1所示的氨基酸序列AEFRHDSGY或其片段,其中第二区域包含氨基酸 酸序列VHHQKLVFFAEDVG,如SEQ ID NO:2所示或其片段。 此外,公开了编码本发明抗体分子的核酸分子和包含所述核酸分子的载体和宿主。 此外,本发明提供包含本发明化合物以及本发明的抗体分子,核酸分子,载体或宿主的特定用途的组合物,优选药物或诊断组合物。
摘要:
The present invention relates to antibody molecules capable of specifically recognizing two regions of the R-A4 peptide, wherein the first region comprises the amino acid sequence ABFRHDSGY as shown in SEQ ID NO: 1 or a fragment thereof and wherein the second region comprises the amino acid sequence VHHQKLVFFAEDVG as shown in SEQ ID NO: 2 or a fragment thereof. Furthermore, nucleic acid molecules encoding the inventive antibody molecules and vectors and hosts comprising said nucleic acid molecules are disclosed. In addition, the present invention provides for compositions, preferably pharmaceutical or diagnostic compositions, comprising the compounds of the invention as well as for specific uses of the antibody molecules, nucleic acid molecules, vectors or hosts of the invention.
摘要翻译:本发明涉及能够特异性识别R-A4肽的两个区域的抗体分子,其中第一区域包含如SEQ ID NO:1所示的氨基酸序列ABFRHDSGY或其片段,其中第二区域包含氨基酸 酸序列VHHQKLVFFAEDVG,如SEQ ID NO:2所示或其片段。 此外,公开了编码本发明抗体分子的核酸分子和包含所述核酸分子的载体和宿主。 此外,本发明提供包含本发明化合物以及本发明的抗体分子,核酸分子,载体或宿主的特定用途的组合物,优选药物或诊断组合物。